CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ceritinib
Accession: CHEBI:78432
browse the term
Definition: A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonyl)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer.
Synonyms: exact_synonym: 5-chloro-N(2)-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N(4)-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine
related_synonym: Formula=C28H36ClN5O3S; InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34); InChIKey=VERWOWGGCGHDQE-UHFFFAOYSA-N; SMILES=N=1C(=NC(=C(C1)Cl)NC=2C(=CC=CC2)S(C(C)C)(=O)=O)NC=3C=C(C(=CC3OC(C)C)C4CCNCC4)C; ZYKADIA; ceritinibum
xref: CAS:1032900-25-6; Drug_Central:4866; LINCS:LSM-36374
xref_mesh: MESH:C586847
xref: PMID:24670165; PMID:24675041; PMID:24789171; PMID:24856155; PMID:24891360; PMID:24963575; PMID:24963576; PMID:24980964; PMID:24984564; PMID:24998601; PMID:25002599; Reaxys:18383989; Wikipedia:Ceritinib
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
ceritinib analog results in decreased expression of and results in decreased phosphorylation of AKT1 protein
CTD
PMID:35803438
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alk
ALK receptor tyrosine kinase
affects response to substance decreases phosphorylation decreases activity
ISO
ALK protein affects the susceptibility to ceritinib ceritinib analog results in decreased phosphorylation of ALK protein ceritinib results in decreased activity of ALK protein
CTD
PMID:26144315 PMID:29458018 PMID:35803438
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
ceritinib analog results in increased expression of BAX protein
CTD
PMID:35803438
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
ceritinib analog results in decreased expression of BCL2 protein
CTD
PMID:35803438
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases cleavage
ISO
ceritinib analog results in increased cleavage of CASP3 protein
CTD
PMID:35803438
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases cleavage
ISO
ceritinib analog results in increased cleavage of CASP9 protein
CTD
PMID:35803438
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cycs
cytochrome c, somatic
affects localization
ISO
ceritinib analog affects the localization of CYCS protein
CTD
PMID:35803438
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Gpt
glutamic--pyruvic transaminase
increases secretion
ISO
ceritinib results in increased secretion of GPT protein
CTD
PMID:29655783
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Jak3
Janus kinase 3
decreases expression
ISO
ceritinib analog results in decreased expression of JAK3 protein
CTD
PMID:35803438
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
ceritinib analog results in decreased expression of and results in decreased phosphorylation of MAPK1 protein
CTD
PMID:35803438
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
ceritinib analog results in decreased expression of and results in decreased phosphorylation of MAPK3 protein
CTD
PMID:35803438
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
ceritinib analog results in decreased expression of MCL1 protein
CTD
PMID:35803438
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
ceritinib analog results in decreased expression of and results in decreased phosphorylation of NFKBIA protein
CTD
PMID:35803438
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Pik3c3
phosphatidylinositol 3-kinase, catalytic subunit type 3
decreases expression
ISO
ceritinib analog results in decreased expression of PIK3C3 protein
CTD
PMID:35803438
NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization multiple interactions
ISO
ceritinib analog affects the localization of RELA protein ceritinib analog results in decreased expression of and results in decreased phosphorylation of RELA protein
CTD
PMID:35803438
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
ceritinib analog results in decreased expression of and results in decreased phosphorylation of STAT3 protein
CTD
PMID:35803438
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Traf2
Tnf receptor-associated factor 2
decreases expression
ISO
ceritinib analog results in decreased expression of TRAF2 protein
CTD
PMID:35803438
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all